Who makes [18F]CSB-321?

[18F]CSB-321 is developed by Cytosite Biopharma Inc..

Last reviewed 2026-04-19 · How we verify

[18F]CSB-321

Cytosite Biopharma Inc. · Phase 1 active Small molecule

At a glance

Generic name	[18F]CSB-321
Also known as	[Al18F]-NODA-CSB-321, CSB-321
Sponsor	Cytosite Biopharma Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]CSB-321 CI brief — competitive landscape report
[18F]CSB-321 updates RSS · CI watch RSS
Cytosite Biopharma Inc. portfolio CI